Ionis Pharmaceuticals Inc, Carlsbad (United States of America)
Follow
Contributor content
Presentation
Inotersen improved quality of life, polyneuropathy and cardiomyopathy in a diverse group of patients with hereditary transthyretin amyloidosis in the phase 3 study NEURO-TTR
